Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
iQIYI to Report First Quarter 2026 Financial Results on May 18, 2026
-
MoneyFlare Launches a Free AI Crypto Trading Bot to Capture 24/7 Market Opportunities
-
Fere AI Raises $1.3M to Put a Self-Improving Trading Agent in Everyone's Hands
-
Fere AI Raises $1.3M to Put a Self-Improving Trading Agent in Everyone's Hands
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - NCC GROUP PLC - Ordinary Shares
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS PLC - 22 04 2026] - (CGWL)
-
Form 8.3 - [ANIMALCARE GROUP PLC - 22 04 2026] - (CGWL)
-
Toobit Adds 36% APR on Solana (SOL) to High-Yield Earn Series
-
Q1, 2026
-
Caisse Française de Financement Local EMTN 2026-4
-
WisdomTree Multi Asset Issuer Public Limited Company Programme for the issuance of Collateralised ETP Securities
-
VEON 2025 Integrated Annual Report: Record Digital Growth, Sovereign AI and Kyivstar Listing Define a Transformative Year
-
Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer
-
Mobile Vikings subscriptions hub powered by the Digital Vending Machine® from Bango
-
Share Buyback Transaction Details April 16 – April 22, 2026
-
IESE Launches Master in Finance for Tomorrow’s Financial Leaders
-
ENA Respiratory Appoints Melissa Faris to Board
-
Zelluna ASA – Annual General Meeting held on April 23, 2026
-
BIGC Unveils BIGC 4.0: The Ultimate All-in-One Enter-Tech Platform for Global K-Pop and K-Culture Fans
-
Last patient, last visit completed in Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
-
Q.ANT Brings Commercial Photonic Computing to the United States, Appoints Bruno Spruth as CTO
-
ArcelorMittal publishes its 2025 Sustainability Report: Safer, smarter growth
-
Michelin: Disclosure of trading in own shares - April 23rd, 2026
-
ArcelorMittal publishes its 2025 Sustainability Report: Safer, smarter growth
-
Hamilton Global Opportunities plc (ALHGO.PA) announces the initiation of coverage of its shares by Euroland Corporate
-
Liquidity Provider Agreement with ABG Sundal Collier ASA
-
BE Semiconductor Industries N.V. Announces Q1-26 Results
-
CSG to Supply Long-Range Artillery Ammunition Worth Almost EUR 250 Million to a European Customer
-
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
-
NORBIT ASA – Notice of Annual General Meeting on 20 May 2026
-
Pharming Group to report first quarter 2026 financial results and provide business update on May 7
-
Directorate change
-
AS Tallink Grupp Unaudited Consolidated Interim Report for the Q1 2026
-
AS-i Tallink Grupp 2026. majandusaasta auditeerimata konsolideeritud I kv tulemuste vahearuanne
-
Lloyd’s syndicate results above average for 2025 with wide disparity at individual syndicate level
-
OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting
-
Orange: Orange achieved very solid first-quarter growth with revenues +3.5% and EBITDAaL +6.6%
-
Eramet: strong turnover momentum in Q1 2026 driven by a solid operational performance
-
WENDEL: Q1 2026 Trading update
-
Interim report: January – March 2026
-
Transaction in Own Shares
-
OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting
-
Press Release: Q1 2026: double-digit sales and business EPS growth
-
Destinus achieves key milestone in next-generation long-range strike capability
-
74Software completes refinancing of its Term Loans and Revolving Credit Facility
-
NORBIT ASA - Annual Report for 2025

